SCHEMBL24253470

SCHEMBL24253470

COCOc1cc(Cl)ccc1-c1cnc(Cl)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
MAPK1 P28482 1/20 0.36
PIK3CA P42336 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
EGFR P00533 2/20 0.33
S1PR4 O95977 1/20 0.32
PLAU P00749 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 1/20 0.32
GRM5 P41594 3/20 0.31
OXTR P30559 1/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
KDM2B Q8NHM5 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24248699 0.82 HSP90AA1 (0.37) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL22338096 0.80 PDE4B (0.41) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL24253574 0.79 EGFR (0.35) HSP90AA1HSP90AB1EGFRS1PR4PLAU
SCHEMBL21412242 0.78 MAPK1 (0.35) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL30131990 0.78 MAPK1 (0.35) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL21412269 0.77 PTGDR2 (0.37) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL30131949 0.77 PTGDR2 (0.37) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL30275020 0.73 CDK9 (0.40) HSP90AA1HSP90AB1MAPK1PIK3CAMAPK8
SCHEMBL21410557 0.73 KCNH2 (0.40)
SCHEMBL25091840 0.71 ALDH1A1 (0.40) HSP90AA1HSP90AB1EGFRS1PR4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 HSP90AA1 2009/4885HSP90AB1 1465/4885MAPK1 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.